Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Cash from Financing Activities (2020 - 2026)

Aura Biosciences filings provide 7 years of Cash from Financing Activities readings, the most recent being $300000.0 for Q1 2026.

  • Quarterly Cash from Financing Activities rose 212.5% to $300000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $77.4 million through Mar 2026, up 5279.62% year-over-year, with the annual reading at $77.2 million for FY2025, 4737.3% up from the prior year.
  • Cash from Financing Activities hit $300000.0 in Q1 2026 for Aura Biosciences, down from $2.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $95.2 million in Q4 2022 and bottomed at $17000.0 in Q1 2022.
  • Average Cash from Financing Activities over 5 years is $16.0 million, with a median of $543000.0 recorded in 2024.
  • The largest annual shift saw Cash from Financing Activities tumbled 99.98% in 2022 before it soared 84151.81% in 2025.
  • Aura Biosciences' Cash from Financing Activities stood at $95.2 million in 2022, then fell by 2.33% to $93.0 million in 2023, then plummeted by 99.42% to $543000.0 in 2024, then skyrocketed by 409.58% to $2.8 million in 2025, then plummeted by 89.16% to $300000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Cash from Financing Activities are $300000.0 (Q1 2026), $2.8 million (Q4 2025), and $4.4 million (Q3 2025).